29 September 2015

Zofran Birth Defects Alleged In New California Lawsuit

September was an active month for the Zofran litigation, and our attorneys have again obtained a number of new complaints filed against GlaxoSmithKline.

At least 50 lawsuits, filed in Federal Courts across the nation, now claim the potent anti-nausea drug caused a child’s birth defects.

On September 1, 2015, a mother from Victorville, California, a small city one hour north of Los Angeles, joined numerous families in claiming the drug caused her unborn daughter G.A. to develop cleft palate and cleft lip.

Her complaint was filed in the US District Court for the Central District of California, and logged as case number 5:15-cv-01780. A copy of the court documents can be viewed below:

View Complaint: 5:15-cv-01780

California Parent Says Zofran Caused Cleft Palate & Cleft Lip

Plaintiff claims she was prescribed Zofran early in a 2012 pregnancy. She continued taking the drug through her second trimester, she says.

Her daughter, named G.A. in court documents, was born on October 10, 2012. Immediately upon delivery, G.A. was diagnosed with what her mother terms “numerous congenital facial defects,” implying that the child’s cleft palate and lip are only a portion of her abnormalities.

While Plaintiff does not discuss G.A.’s treatments, most children born with such orofacial clefts require a series of invasive procedures throughout infancy and on into adolescence. Some require as many as 10 surgeries. In a recent lawsuit, filed in Ohio, a mother claims her child has been forced to undergo 8 surgical repairs to correct orofacial defects.

Highlighting A Link Between Zofran & Cleft Palate

Following a trend begun with the filing of that Ohio lawsuit in mid-July, the mother notes a major study that linked Zofran explicitly to cleft palate. Complaints before July, including ones claiming a child was born with cleft palate, had not referenced this study.

Dubbed the “Anderka” study after its lead author, a team of researchers at Harvard and Boston University reviewed maternal interviews and corresponding birth records to investigate the effects of morning sickness treatments on fetal health. Of more than 75 different drugs, Zofran was among the only medications to be linked to increased risk of birth defects.

The study concluded that mothers prescribed Zofran during the first trimester were 2.37 times more likely to deliver children with cleft palate.

Zofran Birth Defects Lawsuits

At least 50 plaintiffs now eagerly await a decision from the Judicial Panel on Multi-district Litigation. The federal panel is set to determine whether the currently-filed Zofran birth defect lawsuits should be consolidated in a single court. A hearing is scheduled for October 1.

But this in no way restricts the right of other families to file lawsuits of their own. If you or a loved one were prescribed Zofran during the first trimester and went on to deliver a child with major birth defects, contact the attorneys at ZofranLegal.com for a free consultation.